HomeCompareZSAN vs KO

ZSAN vs KO: Dividend Comparison 2026

ZSAN yields 358.68% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZSAN wins by $5209.17M in total portfolio value
10 years
ZSAN
ZSAN
● Live price
358.68%
Share price
$0.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5209.20M
Annual income
$3,364,155,661.75
Full ZSAN calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — ZSAN vs KO

📍 ZSAN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZSANKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZSAN + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZSAN pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZSAN
Annual income on $10K today (after 15% tax)
$30,487.80/yr
After 10yr DRIP, annual income (after tax)
$2,859,532,312.49/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, ZSAN beats the other by $2,859,528,654.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZSAN + KO for your $10,000?

ZSAN: 50%KO: 50%
100% KO50/50100% ZSAN
Portfolio after 10yr
$2604.62M
Annual income
$1,682,079,982.76/yr
Blended yield
64.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

ZSAN
Analyst Ratings
6
Buy
2
Hold
Consensus: Buy
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZSAN buys
0
KO buys
0
No recent congressional trades found for ZSAN or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZSANKO
Forward yield358.68%2.70%
Annual dividend / share$2.00$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$5209.20M$34.1K
Annual income after 10y$3,364,155,661.75$4,303.79
Total dividends collected$5034.10M$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: ZSAN vs KO ($10,000, DRIP)

YearZSAN PortfolioZSAN Income/yrKO PortfolioKO Income/yrGap
1← crossover$46,568$35,868.01$10,846$335.73+$35.7KZSAN
2$205,931$156,102.94$11,829$430.64+$194.1KZSAN
3$865,496$645,150.13$12,988$555.50+$852.5KZSAN
4$3,460,164$2,534,083.72$14,372$721.34+$3.45MZSAN
5$13,170,607$9,468,231.28$16,049$944.01+$13.15MZSAN
6$47,774,260$33,681,710.63$18,114$1,246.74+$47.76MZSAN
7$165,300,693$114,182,234.19$20,702$1,664.24+$165.28MZSAN
8$546,100,449$369,228,707.89$24,008$2,249.48+$546.08MZSAN
9$1,724,339,796$1,140,012,314.98$28,317$3,085.19+$1724.31MZSAN
10$5,209,199,243$3,364,155,661.75$34,065$4,303.79+$5209.17MZSAN

ZSAN vs KO: Complete Analysis 2026

ZSANStock

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full ZSAN Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this ZSAN vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZSAN vs SCHDZSAN vs JEPIZSAN vs OZSAN vs MAINZSAN vs PEPZSAN vs PGZSAN vs JNJZSAN vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.